Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Ruisen Biotechnology is a life science company based in China that specializes in the research, development, and production of high-end biological reagents. The company offers a comprehensive portfolio of products including molecular biology tools, protein purification resins, cell culture reagents, and immunological assay components. Ruisen Biotechnology focuses on core technologies such as protein expression and purification, enzyme engineering, and antibody development to serve the academic and industrial research sectors. Their products are widely used in nucleic acid extraction, PCR amplification, and Western blotting applications. By providing high-quality and cost-effective research tools, the company supports advancements in genomics, proteomics, and clinical diagnostics. The firm also provides custom services including protein expression and antibody preparation to meet specific client needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 青岛睿森生物科技.